Cargando…

Prediction of Cancer Incidence and Mortality in Korea, 2016

PURPOSE: To estimate of Korea’s current cancer burden, this study aimed to report on projected cancer incidence and mortality rates for the year 2016. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2013 were obtained from the Korea National Cancer Incidence Database, and cancer mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kyu-Won, Won, Young-Joo, Oh, Chang-Mo, Kong, Hyun-Joo, Cho, Hyunsoon, Lee, Jong-Keun, Lee, Duk Hyoung, Lee, Kang Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843733/
https://www.ncbi.nlm.nih.gov/pubmed/27034143
http://dx.doi.org/10.4143/crt.2016.092
Descripción
Sumario:PURPOSE: To estimate of Korea’s current cancer burden, this study aimed to report on projected cancer incidence and mortality rates for the year 2016. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2013 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2014 were acquired from Statistics Korea. Cancer incidence in 2016 was projected by fitting a linear regression model to observed age-specific cancer incidence rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly. RESULTS: A total of 254,962 new cancer cases and 75,172 cancer deaths are expected to occur in Korea in 2016. The five leading primary cancer incident sites in 2016 were estimated colorectal, stomach, lung, liver and thyroid cancer in men; thyroid, breast, colorectal, stomach, and lung cancer in women. CONCLUSION: Currently cancer is one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease the nation’s cancer burden will continue to increase as the population ages.